SCHEMBL19062837

SCHEMBL19062837

CO[C@H](c1ccc(N2C[C@@H]3[C@@H](N=C(c4ccccc4)c4ccccc4)[C@]3(I)C2)cc1)[C@@H](CF)N=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14568423 0.83 — —
SCHEMBL13527733 0.83 — —
SCHEMBL14082941 0.75 ACACB (0.32) —
SCHEMBL14082964 0.75 ACACB (0.32) —
SCHEMBL14082445 0.74 ACACB (0.30) —
SCHEMBL14083228 0.74 PDE2A (0.31) —
SCHEMBL14082954 0.74 ACACB (0.31) —
SCHEMBL14082385 0.73 ACACB (0.34) —
SCHEMBL14083195 0.72 RORC (0.32) —
SCHEMBL14083394 0.72 GRIN2B (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934238-B1 TRIAZOLE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2017-06-28 — — EP disclosed
Send feedback